Cure3 calls for artists to create an original piece of work in a Perspex cube – all in the name of Parkinson’s research. We find out more about the focus of this year’s fundraising exhibition
The third edition of the Cure3 exhibition, which raises money for UK charity Cure Parkinson’s Trust, brings together original artwork from 80 renowned international artists – and, in a special addition to this year’s event, creations from 11 fashion designers.
This year’s line-up sees top designers including Roksanda Ilinčić, Giles Deacon and Monika Dugar joining artists likeConrad Shawcross, Ron Arad, Rana Begum, Annie Morris and Idris Khan, in raising funding for Parkinson’s research.
The selling exhibition, which will take place from 5-8 September this year, challenges artists to create a new piece of artwork in a bespoke Perspex cube, which measures just 20cm3. This format is inspired by the ‘boxed in’ feeling of the condition, described by Cure Parkinson’s Trust founder, Tom Isaacs.
Since its launch in 2017, the project has raised more than £750,000. The Cure3 team hope to reach £1m of fundraising through artwork sales, alongside profits from a specially designed scarf created by heritage brand, Richard Allan London.
“It is about representing the hope that one-day we will be able to find a cure”
Some of the Cure3 artists cite a personal connection to the condition as a reason for taking part in the exhibition.
Award-winning designer Giles Deacon says: “I mainly work with charities that have a personal resonance and due to the fact that I have three close friends with Parkinson’s, it gives the initiative added meaning.”
Designer Giles Deacon, with his Cure3 cube.
Bouke de Vries, who specialises in ceramics and porcelain, says his partner’s Parkinson’s motivated him to take part: “Anything I can do to work towards a cure is my duty.”
Artist Mali Morris, who has designed a cube containing a colourful concertina of paper, created her piece in memory of her father, sister-in-law, and friend John McLean, who all had Parkinson’s.
Artist Mali Morris, with her design.
Other artists have created pieces inspired by the condition itself. “I began thinking about the cube and that I might make a coloured box of wool,” says contemporary artist and sculptor, Andy Goldsworthy. “I just grabbed a lump of fleece and rammed it into the box not really knowing what to expect. The transformation was extraordinary. It was like looking into another world. Afterwards I remembered that the farmer who owns the sheep around my home has Parkinson’s.”
Fashion designer Roksanda Ilinčić, took a different approach, working with textiles to reflect her thoughts on the future of Parkinson’s treatment.
“Using the specially designed print, the fabric has been moulded into the abstract shape of a brain to signify a perfectly functioning mind with all the creative thoughts and ideas represented through the contrasting colours and patterns. It is about representing the hope that one day we will be able to find a cure for Parkinson’s.”
Find out more about Cure3
For a limited time before the exhibition, some of the Cure3 artwork will be on display in the windows of London department store Fenwick. Cubes created for the exhibition will be available to buy on its website from 8am, 8 September and will also be displayed at Bonhams, an auction house in London, UK.
Our new campaign centres the experiences of women with Parkinson’s
5 days ago
Researchers have finally identified brain cells linked to Parkinson’s disease
For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…
Tiny DBS implant shows potential to advance Parkinson’s disease treatment
In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”
Could a specialised smartwatch support people with Parkinson’s disease?
A specialised smartwatch, which could help those living with Parkinson’s to better manage their condition, will be rolled out to thousands of people in England. The Parkinson’s Kinetigraph, developed by the National Health Service (NHS) in Plymouth and the University of Plymouth, UK, contains sensors designed to monitor the wearer’s activity and buzz with medication reminders. Data collected from the watch – which detects excessive movement, immobility and sleep disturbances – is shared with healthcare providers, allowing for improvements to physiotherapy and prescriptions based on patient needs. Commenting on the smartwatch’s launch, NHS England chief executive Amanda Pritchard said: “Not only is it better for these people living with Parkinson’s, but it is also more efficient for the NHS, freeing up space and time in hospitals for our hard-working staff.” UK health secretary Sajid Javid, meanwhile, described the Kinetigraph as a “fantastic example of how technology is driving cutting-edge innovation…